Pay in 4 interest-free payments of $7.33 Learn more
Ships within 48 hours Β· Estimated delivery Aug 7 - Aug 12
A larger clinical trial randomly assigned more than 500 patients with type 2 diabetes and symptomatic peripheral neuropathy to one of the following treatments: (i) 600 mg/day of intravenous lipoic acid for three weeks followed by 1,800 mg/day of oral lipoic acid for six months, (ii) 600 mg/day of intravenous lipoic acid for three weeks followed by oral placebo for six months, or (iii) intravenous placebo for three weeks followed by oral placebo for six months (76)
FAQs Add To Cart Buy Now
PubMed laboratory research record [PMID: 39006466] PubMed record related to this compound for laboratory literature review
Staying at each dose level longer allows your intestinal tissue to develop tolerance before moving up, significantly reducing diarrhea severity
"Brain-gut Axis and Pentadecapeptide BPC 157: Theoretical and Practical Implications." Current Neuropharmacology 14.8(2016).
JAMA Ophthalmology
US$ 25.00
US$ 24.57
US$ 28.46
US$ 22.09
